Exclusive owner of patent-protected BioFarming technology Grows plant cells at industrial scale in liquid bioreactors to produce the secondary...
Silver North Resources (TSX-V:SNAG, OTCQB:TARSF), which rebranded during 2023 to emphasize the...
Nike Inc (NYSE:NKE, ETR:NKE)'s fiscal third quarter profits are expected to take a hit from...
Xeris Biopharma CEO Paul Edick joined Steve Darling from Proactive to share news the company had a successful 2023, with a final tally of 164 million USD, which is at the upper end of their forecast. The company concluded the year with 72 million USD in cash, surpassing their initial projections...